See our roundup of today's AIM risers - see the full LSE winners & losers board here.

GCM Resources rises 14% to 13.5p a share

GCM Resources (GCM)  signed a memorandum of understanding with Power Construction Corporation of China to develop a proposed coal mine and power plants to generate 4,000 MW at the site.

The MOU aims to conclude a Joint Development Agreement by 31 December 2018, and to submit a formal proposal to the Government of Bangladesh by 28 February 2019.

Executive Chairman of GCM, Datuk Michael Tang PJN, stated: “GCM's strategy is to present a holistic power solution to the Government of Bangladesh which can generate 6,000MW for the country.

Read more here & follow GCM here: 

Haydale Graphene rises 8% to 39p a share

Haydale Graphene (HAYD)  last week announced it signed an exclusive license agreement for 3 years and 3 months to access its patented anti-counterfeiting technology in commercial applications with a printing firm in Thailand.

Shares surged 20% yesterday to 32.25p a share and have continued to rise

Read more here & follow HAYD here: 

OptiBiotix Health rises 13% to 83p a share

OptiBiotix (OPTI)  announced its SlimBiome has been granted medical device status and a CE mark.

This will allow it to be freely marketed to all countries in the EEA and markets with mutual recognition agreements, and follow a shorter registration procedure in other international markets.

Stephen O'Hara, CEO of OptiBiotix, commented: "We are excited that after two years of working with manufacturers and European regulatory bodies, SlimBiome® has been granted medical device status and a CE mark.”

SlimBiome has been clinically proven to make consumers feel fuller, less hungry, experience less food cravings and change food choices to less sweet and fatty foods

Read more here & follow OPTI here: 

Rose Petroleum rises 8% to 2.5p a share

Rose Petroleum (ROSE)  US subsidiary VANE minerals, has been issued shares valued at $300,000 in encore Energy Corporation for access to its uranium project database. 

After a 4 month period Rose will be able to dispose of the shares, and for an initial 5 years, ENCORE will use the data to develop prospects into commercial operations in which VANE will have a one-off opportunity to participate in for a maximum of 25% working interest.

Matthew Idiens, CEO, said: “The joint venture Agreement with ENCORE, in addition to the disposals of the Group's Wate project and the SDA mill in Mexico last year, is in line with our strategy of creating value from our non-core assets whilst focusing on our onshore North-American oil and gas activities."

Read more here & follow ROSE here: ​​​​​​

See all today's AIM Risers here